Journals / Bozok Tıp Dergisi / 2015 / Cilt: 5 Sayı: 1

ENDOMETRİAL KANSER SAPTANAN OLGULARDA OPERASYON SONUÇLARININ VE BAZI PROGNOSTİK FAKTÖRLERİN DEĞERLENDİRİLMESİ

Pages
18–24
Publication Date
2015-02-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Al though the treatment modalities can change in accordance with stage of tumor and patients’ health status, surgery appears as the standard treatment modality

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Endometrial cancer is the fourth leading cancer among women in the world and consists of nearly half of all gyneco logical cancers.
📊
Key Findings & Data:Our aim was to report surgical results and prognosis of endometrial cancer diagnosed in our clinic.Methods: Fourty two endometrial cancer patients diagnosed and treated surgically between 2010 and 2013 were analyzed retrospectively.
💡
Conclusion & Impact:Al though the treatment modalities can change in accordance with stage of tumor and patients’ health status, surgery appears as the standard treatment modality
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Endometriyum kanseri · Prognoz · Cerrahi tedavi

Abstract

Purpose: Endometrial cancer is the fourth leading cancer among women in the world and consists of nearly half of all gyneco logical cancers. Our aim was to report surgical results and prognosis of endometrial cancer diagnosed in our clinic.Methods: Fourty two endometrial cancer patients diagnosed and treated surgically between 2010 and 2013 were analyzed retrospectively. Clinical and surgical data of the patients, histopathological and prognostic parameters related to outcomes were evaluated. The patients undergone type 3 hysterectomy or the patients who couldn’t be differentially diagnosed from cervical cancer were excluded.Results: According to the American Joint Committee on Cancer classification, 29 patients (69%) were found to have in stage 1, 5 patients in stage 2 (12%), 4 patients in stage 3 (9%) and 4 patients (10%) in stage 4 respectively. Approximately half of the patients (n = 14) (48.2%) in stage 1 had endometrially limited tumor with myometrial invasion of <1/2, or grade 1 tumor and all were undergone TAH+BSO. The rest of patients in stage 1 were additionally undergone pelvic para-aortic lymph node dissection (PPLND), omentec tomy and appendectomy. Mean number of removed lymph nodes 41.14. Stromal lymphovascular invasion (LVS) were found in 14 patients (33.3%). Wound infec tion and evisceration was developed in one patient. Three wound infection, one atelectasis, one ureter injury and one pulmonary embolism were developed in patients with PPLND. Age of patients in the earlier stages was lower. The age distribution of patients was found to increase with increase in the stage of the tumor.Conclusion: Endometrial cancers can be diagnosed in earlier stages Due to early clinic symptoms compared to other gynecological cancers. Al though the treatment modalities can change in accordance with stage of tumor and patients’ health status, surgery appears as the standard treatment modality

Özet

ÖZETAmaç: Endometriyum kanseri dünyada kadınlar arasında dördüncü sırada görülmekte, jinekolojik kan-serlerin ise yaklaşık yarısını oluşturmaktadır. Amacımız kliniğimizdeki endometriyum kanserli olgularıncerrahi tedavi sonuçları ve prognozlarını paylaşmaktır.Gereç ve Yöntemler: 2010- 2013 yılları arasında endometrium kanseri tanısı alıp opere edilen 42hastanın dosyaları retrospektif olarak incelenip, hastaların klinik özellikleri, operasyon tipleri, his-topatolojik özellikleri ve prognostik faktörleri ile ilgili sonuçlar değerlendirilmiştir. Serviks kanserindenayrımı yapılamayan olgular veya tip 3 histerektomi yapılmak zorunda kalınan olgular çalışmaya dahiledilmemiştir.Bulgular: American Joint Committee on Cancer’in belirlediği sınıflama sistemine göre 29 hasta (% 69)evre 1, 5 hasta evre 2 (% 12), 4 hasta evre 3 (% 9) ve 4 hasta (% 10) evre 4 olarak bulunmuştur. Evre 1’debulunan hastaların yaklaşık yarısında n=14 (% 48,2) tümör endometriumda sınırlı, myometrial invazyon< ½ veya grade 1 olarak rapor edilmiş ve total abdominal histerektomi ve bilateral salpingo-ooforektomiuygulanmıştır. Kalan hastalara TAH+BSO ilave olarak pelvik paraaortik lenf nodu diseksiyonu (PPLND),omentektomi ve appendektomi ilave edilmiştir. PPLND uygulanan 28 hastada ortalama olarak 41,14lenf nodu çıkarılmıştır. Hastalardan 14’ünde (% 33,3) lenfovasküler stromal invazyon (LVSI) bulunmuştur.TAH+BSO yapılan olguların birinde yara yeri enfeksiyonu ve evisserasyon; lenf nodu diseksiyonu eklenenhastaların üçünde yara yeri enfeksiyonu, birinde atelektazi, birinde üreter yaralanması ve bir tanesindepulmoner emboli gelişmiştir. Hastaların yaş dağılımı incelendiğinde erken evredeki hastaların yaşlarınındaha düşük olduğu buna karşın evre ilerledikçe yaş dağılımının arttığı bulunmuştur.Sonuç: Endometrial kanserli olgular, diğer jinekolojik kanserlere göre daha erken bulgu vermesi sebe-biyle erken evrelerde yakalanabilmektedir. Hastaların evresi ve genel durumuna göre tedavi şekillerideğişmesine rağmen cerrahi standart bir tedavi olmuştur.Anahtar kelimeler: Endometriyum kanseri; Prognoz; Cerrahi tedaviABSTRACTPurpose: Endometrial cancer is the fourth leading cancer among women in the world and consists ofnearly half of all gynecological cancers. Our aim was to report surgical results and prognosis of endome-trial cancer diagnosed in our clinic.Methods: Fourty two endometrial cancer patients diagnosed and treated surgically between 2010 and2013 were analyzed retrospectively. Clinical and surgical data of the patients, histopathological andprognostic parameters related to outcomes were evaluated. The patients undergone type 3 hysterec-tomy or the patients who couldn’t be differentially diagnosed from cervical cancer were excluded.Results: According to the American Joint Committee on Cancer classification, 29 patients (69%) werefound to have in stage 1, 5 patients in stage 2 (12%), 4 patients in stage 3 (9%) and 4 patients (10%) instage 4 respectively. Approximately half of the patients (n = 14) (48.2%) in stage 1 had endometriallylimited tumor with myometrial invasion of <1/2, or grade 1 tumor and all were undergone TAH+BSO.The rest of patients in stage 1 were additionally undergone pelvic para-aortic lymph node dissection(PPLND), omentectomy and appendectomy. Mean number of removed lymph nodes 41.14. Stromallymphovascular invasion (LVS) were found in 14 patients (33.3%). Wound infection and evisceration wasdeveloped in one patient. Three wound infection, one atelectasis, one ureter injury and one pulmonaryembolism were developed in patients with PPLND. Age of patients in the earlier stages was lower. Theage distribution of patients was found to increase with increase in the stage of the tumor.Conclusion: Endometrial cancers can be diagnosed in earlier stages Due to early clinic symptoms com-pared to other gynecological cancers. Although the treatment modalities can change in accordance withstage of tumor and patients’ health status, surgery appears as the standard treatment modality.Key words: Endometrial cancer; Prognosis; Operative therapy

🔖

Cite This Article

AÇMAZ, G., AKSOY, H., CINGILLIOĞLU, B., MADENDAĞ, Y., AKSOY, Ü., ÖZYURT, S., UYSAL, G. (2015). ENDOMETRİAL KANSER SAPTANAN OLGULARDA OPERASYON SONUÇLARININ VE BAZI PROGNOSTİK FAKTÖRLERİN DEĞERLENDİRİLMESİ. Bozok Tıp Dergisi, Cilt: 5 Sayı: 1, 18–24. https://ajindex.com/articles/925863

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Greenlee RT, Murray T, Bolden S. Cancer statistic; 2000. CA Cancer J Clin. 2000;50(1):7-33.
  2. Atasü T, Şahmay S. Jinekoloji (Kadın Hastalıkları). In: Atasü T, Şahmay S, eds. 2. Baskı. İstanbul: Nobel Tıp Kitapevi. 2001:299-314. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Onco1. 1983;15(1):10-7.
  3. Lurain JR, Rice BL, Rademaker AW. Prognostic factors associated with recurrence in clinical stage 1 adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78(1):63-9.
  4. Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract. New York: Springer-Verlag. 1994:439-86. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105(2):109. Guyatt GH, Akl EA, Crowther M. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(1):7-47. Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin No. 84. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2007;110(2):429-40. American Joint Committee on Cancer. Corpus Uteri. In Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (eds). AJCC Staging Manual, 7th. edition. New York. Springer. 2010. p. 403. Çiçek MN, Akyürek C, Çelik Ç, Haberal A. Korpus Uterinin Premalign ve Malign Hastalıkları. In: Özgünen T, ed. Kadın Hastalıkları ve Doğum Bilgisi. Ankara. 2. Baskı. Güneş Kitapevi. 2004. p. 1179-205.
  5. Kars B, Ünal Ö, Kalender HS. Endometrial Kanser Operasyon Sonuçlarının ve Bazı Prognostik Faktörlerin Değerlendirilmesi Türk Jinekolojik Onkoloji Dergisi. 2010;13(2):36-42.
  6. Kösebay D, Beşe T, Erkün E. Endometrium kanserinde sağ kalım ve hastalıksız yaşam süresine etki eden prognostik faktörlerin değerlendirilmesi. Türkiye Klinikleri Jinekoloji ve Obstetrik Dergisi. 1996;6(4):259-69.
  7. Chi DS, Barakat RR, Palayekar MJ. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18(2):269-73.
  8. Creasman WT, Morrow CP, Bundy BN. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60(8):2035-41.
  9. Frumovitz M, Singh DK, Meyer L. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95(3):463–8.
  10. Mohan DS, Samuels MA, Selim MA. Long-term o